ArticleJCI insight2025

TYRA-300, an FGFR3-selective inhibitor, promotes bone growth in two FGFR3-driven models of chondrodysplasia.

Jacqueline H Starrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.